Author + information
- Received January 26, 2017
- Revision received February 22, 2017
- Accepted February 22, 2017
- Published online March 17, 2017.
- Tanveer Rab, MD1,∗ (, )
- Imad Sheiban, MD2,
- Yves Louvard, MD3,
- Fadi J. Sawaya, MD4,
- Jun JIe Zhang, MD5 and
- Shao Liang Chen, MD5
- 1Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
- 2Division of Cardiology, University of Turin, Turin, Italy
- 3Divsion of Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France
- 4Division of Cardiology, American University of Beirut, Beirut, Lebanon
- 5Division of Cardiology, Nanjing Medical University, Nanjing, China
- ↵∗Corresponding author: Tanveer Rab, MD Division of Cardiology, Emory University School of Medicine Atlanta, Georgia, USA Tel: 404-277-6311.
Contemporary clinical trials, registries and meta analyses (1-5), supported by recent results from the EXCEL(6) and NOBLE(7) trials have established percutaneous coronary intervention (PCI) of left main(LM) coronary stenosis as a safe alternative to coronary artery bypass grafting (CABG) in patients with low and intermediate syntax scores (6,8-10). As LM PCI gains acceptance, it is imperative to increase awareness of patient selection, risk scoring, intracoronary imaging, vessel preparation and choice of stenting techniques that will optimize procedural and patient outcomes.
Conflict of Interest:
- Received January 26, 2017.
- Revision received February 22, 2017.
- Accepted February 22, 2017.